| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 299,429 | 308,903 | 315,837 | 293,636 | | Cost of Revenue | 146,019 | 165,172 | 166,473 | 160,228 | | | Gross Profit | 153,410 | 143,731 | 149,364 | 133,408 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 76,334 | 62,051 | 53,534 | 68,442 | | Non Recurring | 12 | 43 | 52 | 186,082 | | Others | 26,106 | 26,229 | 26,472 | 26,994 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 50,958 | 55,408 | 69,306 | (148,793) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 794 | (3,886) | (307) | (1,520) | | Earnings Before Interest And Taxes | 51,752 | 51,522 | 68,999 | (149,630) | | Interest Expense | 30,100 | 25,602 | 16,915 | 19,790 | | Income Before Tax | 21,652 | 25,920 | 52,084 | (169,420) | | Income Tax Expense | 7,190 | 11,639 | 22,184 | (68,323) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,097 | 14,281 | 29,900 | (101,097) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,462 | 14,281 | 29,900 | (101,097) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,462 | $14,281 | $29,900 | ($101,097) |
|
1.52% Nasdaq 
Income Statement
